Posted on

Phase 1 COVID-19 Vaccine Trial Launched

v1 220th sm uoiqpifjyk02 1539120930 6714

the staff of the Ridgewood blog

Washington DC, On Monday, the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health announced that a Phase 1 clinical trial evaluating an investigational vaccine designed to protect against COVID-19 has begun at Kaiser Permanente Washington Health Research Institute in Seattle, funded by NIH.

Continue reading Phase 1 COVID-19 Vaccine Trial Launched